Momentis gains FDA clearance for second generation surgical robot

Portfolio CompaniesLIP Fund I
Written By Federico de Mateo

Momentis Surgical Ltd. received 510 (k) clearance from the U.S. FDA for the second-generation of the Anovo robotic surgical platform. The upgraded system allows surgeons to experience enhanced ergonomics with integrated haptic feedback, creating more intuitive control of the robotic arms during surgical procedures.

Read More on Bioworld
Federico de Mateo
Previous

Terra Appoints Pete Lyons as CEO to Lead Commercial Scale-Up
Next

JumpCloud report finds AI agent adoption surging while governance and oversight lag